Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Intrapatient Changes in CT-Based Body Composition After Initiation of Semaglutide (Glucagon-Like Peptide-1 Agonist) Therapy

Published:2024-09-04 Issue: Volume: Page:
ISSN:0361-803X
Container-title:American Journal of Roentgenology
language:en
Short-container-title:American Journal of Roentgenology

Author:

Nelson Leslie W.¹,Lee Matthew H.¹,Garrett John W.¹,Pickhardt Silas G.¹,Warner Joshua D.¹,Summers Ronald M.¹,Pickhardt Perry J.¹

Affiliation:

1. The Departments of Radiology and Medical Physics, University of Wisconsin School of Medicine & Public Health, Madison, WI, USA

Publisher

American Roentgen Ray Society

Reference47 articles.

1. World Health Organization. Obesity and overweight. https://www.who.int/news-room/factsheets/detail/obesity-and-overweight. 3/1/2024 [cited 6/29/2024].

2. Medications and conditions associated with weight loss in patients prescribed semaglutide based on real‐world data

3. Wegovy (semaglutide): a new weight loss drug for chronic weight management

4. Semaglutide and effective weight control

5. Semaglutide for the treatment of obesity

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP